Maternal and infant outcomes among women vaccinated against pertussis during pregnancy

Abbey B. Berenson, Jacqueline M. Hirth, Mahbubur Rahman, Tabassum H. Laz, Richard E. Rupp, Kwabena O. Sarpong

Research output: Contribution to journalArticle

23 Scopus citations


Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination is recommended for all women during each pregnancy to prevent pertussis in young infants. However, data on the safety of this protective measure are limited and conflicting. To assess maternal and infant outcomes associated with administration of this vaccine during pregnancy, we reviewed medical records of 1,759 women who delivered a singleton infant at a southeast Texas public hospital between November 1, 2012 and June 30, 2014. After excluding women who had inadequate prenatal care or who delivered at

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalHuman Vaccines and Immunotherapeutics
StateAccepted/In press - May 5 2016



  • infant outcomes
  • maternal outcomes
  • pertussis
  • pregnancy
  • Tdap
  • vaccination
  • vaccine safety

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this